CSIMarket

Thermo Fisher Scientific Inc   (TMO)
Other Ticker:  
 
 
Price: $555.2100 $0.06 0.011%
Day's High: $560.79 Week Perf: 0.11 %
Day's Low: $ 553.66 30 Day Perf: -1.08 %
Volume (M): 43 52 Wk High: $ 672.34
Volume (M$): $ 23,843 52 Wk Avg: $567.46
Open: $558.92 52 Wk Low: $438.72



 Market Capitalization (Millions $) 219,308
 Shares Outstanding (Millions) 395
 Employees 75,000
 Revenues (TTM) (Millions $) 41,123
 Net Income (TTM) (Millions $) 7,611
 Cash Flow (TTM) (Millions $) -2,824
 Capital Exp. (TTM) (Millions $) 2,535

Thermo Fisher Scientific Inc
Thermo Electron Corporation is a world leader in high-tech instruments. The company helps life science, laboratory, and industrial customers advance scientific knowledge, enable drug discovery, improve manufacturing processes, and protect people and the environment with instruments, scientific equipment, services, and software solutions. The company's powerful technologies help researchers make discoveries that will fight disease or prolong life. They automatically monitor and control online production to ensure the quality and safety of raw materials as well as the end products. And they are critical components embedded as enabling technologies within scientific and industrial devices.

Our strategy going forward is to focus on internal growth by pursuing developments in the markets that we serve that have potential for high growth. Our strategy is also to continue to improve productivity, enabling us to better serve our customers with improved products, technologies, and complete integrated systems and services. In addition, we plan to augment that growth with strategic acquisitions that expand the reach of our technology by either rounding out our product lines or bringing them to new markets.


We report our business in two principal segments: Life and Laboratory Sciences, Measurement and Control.

Competition


Life and Laboratory Sciences

Bioscience Technologies. In the markets served by this division, our principal competitors include Eppendorf AG; Gilson, Inc.; Tecan Group Ltd.; PerkinElmer, Inc.; Molecular Devices Corp.; Kendro Laboratory Products (a subsidiary of SPX Corporation); and Beckman Coulter, Inc.

Scientific Instruments. In the markets served by this division, our principal competitors include Applied Biosystems Inc.; Agilent Technologies Inc.; Waters Corporation; Shimadzu Corporation; PerkinElmer; Bruker Daltonics Inc.; Hitachi, Ltd.; and Varian Inc.

Informatics and Services. In the markets served by this division, our principal competitors include PerkinElmer; Applied Biosystems; Beckman Coulter; Agilent; and LabVantage Solutions.

Clinical Diagnostics. In the markets served by this division, our principal competitors include Leica Microsystems; Sakura Finetechnical Co., Ltd.; Becton, Dickinson and Company; Quidel Corporation; and Roche-Boeringher Manheim.

Measurement and Control

Process Instruments. In the markets served by this division, our principal competitors include Mettler-Toledo International Inc.; Yokogawa Electric Corporation; Fisher-Rosemount (a division of Emerson Electric Co., Inc.); Asea Brown Boveri (Holding) Ltd.; Endress & Hauser; Integrated Measurement Systems, Inc.; and Antek Instruments, Inc.

Environmental Instruments. In the markets served by this division, our principal competitors include Danaher Corporation; Mettler-Toledo; Horiba; Fisher-Rosemount; Teledyne Advanced Pollution Instrumentation, Inc.; RAE Systems Inc.; ISC; Canberra Industries, Inc.; synOdys Group; GE Interlogix; and Smiths- Barringer.

Control Technologies. In the markets served by this division, our principal competitors include SMC; Lytron Inc.; Julabo; TA Instruments; Gottfert; Brabender; and MDC.



   Company Address: 168 Third Avenue Waltham 2451 MA
   Company Phone Number: 622-1000   Stock Exchange / Ticker: NYSE TMO
   TMO is expected to report next financial results on August 05, 2022.


Customers Net Income grew by TMO's Customers Net Profit Margin grew to

44.93 %

12.01 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

Year to Date Decrease / Increase
     
PKI   -23.79%    
ABT   -17.27%    
GE   -21.59%    
HON   -8.33%    
JNJ        4.61% 
MMM   -18.77%    
• View Complete Report
   



Propanc Biopharma Inc.

Propanc Biopharma Inc announced third quarter of 2022 operating deficit of $-0.502181 millions

In the third quarter of 2022 Propanc Biopharma Inc decreased loss of $-0.01 per share compared to $-0.12 a year ago and improved from $-0.02 per share from the previous quarter.

Fortune Valley Treasures Inc.

EPS $0.01, Sales Faded

In the financial first quarter of 2022 Fortune Valley Treasures Inc eps of $0.01 per share compared to $0.00 a year ago and from $0.00 per share from the previous quarter.

Good Gaming Inc.

Critical quarter for Good Gaming Inc in the first quarter of 2022 earnings season

Good Gaming Inc recorded operating deficit of $-0.477769 millions, in the first quarter of 2022 earnings season, a degradation from the operating loss of $-0.098597 millions, reported in first quarter of 2021

Shineco Inc.

Shineco Inc disclosed financial time-frame ending Mar 31 2022 operating shortfall of $-2.727184 millions

Shineco Inc announced very strong Sales growth of 9136.31% year on year to $0.62 millions in the financial time-frame ending Mar 31 2022, but loss increased at $-0.30.

Gbs Inc.

Gbs Inc declared exceptional results in the fiscal span ending Mar 31 2022

Gbs Inc announced very strong Sales growth of 2776.57% year on year to $0.19 millions in the fiscal span ending Mar 31 2022, but loss increased at $-0.09.






 

Thermo Fisher Scientific Inc 's Segments
 
Laboratory Sciences
 Segment    38.33 % of total Revenue
Measurement & Control
 Segment    18.21 % of total Revenue
Specialty Diagnostics
 Segment    18.18 % of total Revenue
Life Sciences Solutions
 Segment    25.28 % of total Revenue
 
• View Complete Report
  Company Estimates  
  Revenue Outlook
Thermo Fisher Scientific Inc does not provide revenue guidance.

Earnings Outlook
Gbs Inc. does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States 52.01 %
England 4.82 %
Germany 6.42 %
Other 36.76 %


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RMED's Profile

Stock Price

RMED's Financials

Business Description

Fundamentals

Charts & Quotes

RMED's News

Suppliers

RMED's Competitors

Customers & Markets

Economic Indicators

RMED's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071